Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-04

Clinical Trial Update: Eszopiclone Treatment & Cortisol Responsivity [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating eszopiclone for insomnia with cortisol responsivity outcomes; study completed and results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eszopiclone (eszopiclone)

Snippet

Sponsor: Butler Hospital | Conditions: Insomnia | Phase 4 | Status: COMPLETED | Results posted: 2014-11-04